Structure and interaction modes of thrombin.

[1]  K. Mann,et al.  The isomorphous structures of prethrombin2, hirugen–, and PPACK–thrombin: Changes accompanying activation and exosite binding to thrombin , 1994, Protein science : a publication of the Protein Society.

[2]  S. W. Hall,et al.  A thrombin receptor function for platelet glycoprotein Ib-IX unmasked by cleavage of glycoprotein V. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Robert Huber,et al.  Structural basis for the anticoagulant activity of the thrombin–thrombomodulin complex , 2000, Nature.

[4]  Weiqi Wang,et al.  Elements of the Primary Structure of Thrombomodulin Required for Efficient Thrombin-activable Fibrinolysis Inhibitor Activation* , 2000, The Journal of Biological Chemistry.

[5]  H Oschkinat,et al.  The interaction of thrombin with fibrinogen. A structural basis for its specificity. , 1992, European journal of biochemistry.

[6]  R. Huber,et al.  Crystal structure of the human α‐thrombin–haemadin complex: an exosite II‐binding inhibitor , 2000, The EMBO journal.

[7]  R. Huber,et al.  Characterization of the residues involved in the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor. , 2002, Biochemistry.

[8]  J. Herbert,et al.  The ternary complex of antithrombin–anhydrothrombin–heparin reveals the basis of inhibitor specificity , 2004, Nature Structural &Molecular Biology.

[9]  P. Fay.  Activation of factor VIII and mechanisms of cofactor action. , 2004, Blood reviews.

[10]  R. Huber,et al.  Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation , 2003, Nature.

[11]  K. Mann,et al.  The crystal structure of activated protein C-inactivated bovine factor Va: Implications for cofactor function , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[12]  C. Esmon,et al.  Structure of the antithrombin–thrombin–heparin ternary complex reveals the antithrombotic mechanism of heparin , 2004, Nature Structural &Molecular Biology.

[13]  E. Di Cera,et al.  Molecular mapping of thrombin‐receptor interactions , 2001, Proteins.

[14]  A. Tulinsky,et al.  Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin. , 1994, Biochemistry.

[15]  E. Di Cera,et al.  Thrombomodulin Changes the Molecular Surface of Interaction and the Rate of Complex Formation between Thrombin and Protein C* , 2005, Journal of Biological Chemistry.

[16]  J. Freyssinet,et al.  Anti-thrombin activities of heparin. Effect of saccharide chain length on thrombin inhibition by heparin cofactor II and by antithrombin. , 1989, The Biochemical journal.

[17]  C. Foster,et al.  Unique Pathway of Thrombin-induced Platelet Aggregation Mediated by Glycoprotein Ib* , 2001, The Journal of Biological Chemistry.

[18]  W. Bode,et al.  Comparative Analysis of Haemostatic Proteinases: Structural Aspects of Thrombin, Factor Xa, Factor IXa and Protein C , 1997, Thrombosis and Haemostasis.

[19]  J. Huntington,et al.  Molecular recognition mechanisms of thrombin , 2005, Journal of thrombosis and haemostasis : JTH.

[20]  E. Di Cera,et al.  Molecular mechanisms of thrombin function , 1997, Cellular and Molecular Life Sciences CMLS.

[21]  S. W. Hall,et al.  Structural and functional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib. , 2001, Biochemistry.

[22]  C. Esmon,et al.  New insights into the regulation of the blood clotting cascade derived from the X-ray crystal structure of bovine meizothrombin des F1 in complex with PPACK. , 1997, Structure.

[23]  C. Esmon,et al.  The roles of protein C and thrombomodulin in the regulation of blood coagulation. , 1984, The Journal of biological chemistry.

[24]  Y. Li,et al.  Identification of basic amino acid residues in thrombin essential for heparin-catalyzed inactivation by antithrombin III. , 1994, The Journal of biological chemistry.

[25]  R. Huber,et al.  The ornithodorin‐thrombin crystal structure, a key to the TAP enigma? , 1996, The EMBO journal.

[26]  A. Tulinsky,et al.  Structure of the hirugen and hirulog 1 complexes of alpha-thrombin. , 1991, Journal of molecular biology.

[27]  R. Huber,et al.  Structure of the thrombin complex with triabin, a lipocalin-like exosite-binding inhibitor derived from a triatomine bug. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[28]  P. Walsh,et al.  Thrombin Activation of Factor XI on Activated Platelets Requires the Interaction of Factor XI and Platelet Glycoprotein Ibα with Thrombin Anion-binding Exosites I and II, Respectively* , 2003, Journal of Biological Chemistry.

[29]  W. Bode,et al.  Two heads are better than one: crystal structure of the insect derived double domain Kazal inhibitor rhodniin in complex with thrombin. , 1995, The EMBO journal.

[30]  G. Gilliland,et al.  Crystal structure of the complex between thrombin and the central "E" region of fibrin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  D. Banner,et al.  Crystallographic analysis at 3.0-A resolution of the binding to human thrombin of four active site-directed inhibitors. , 1994, The Journal of biological chemistry.

[32]  E. Di Cera,et al.  Hirudin Binding Reveals Key Determinants of Thrombin Allostery* , 2005, Journal of Biological Chemistry.

[33]  Alireza R Rezaie,et al.  The Fourth Epidermal Growth Factor-like Domain of Thrombomodulin Interacts with the Basic Exosite of Protein C* , 2003, The Journal of Biological Chemistry.

[34]  C. Esmon,et al.  Glycosaminoglycan contributions to both protein C activation and thrombin inhibition involve a common arginine-rich site in thrombin that includes residues arginine 93, 97, and 101. , 1994, The Journal of biological chemistry.

[35]  Elizabeth A. Komives,et al.  Solution structure of the smallest cofactor-active fragment of thrombomodulin , 2000, Nature Structural Biology.

[36]  E. Huizinga,et al.  The GPIbα–thrombin interaction: far from crystal clear , 2004 .

[37]  S. Krishnaswamy,et al.  The Affinity of Protein C for the Thrombin·Thrombomodulin Complex Is Determined in a Primary Way by Active Site-dependent Interactions* , 2005, Journal of Biological Chemistry.

[38]  W. Bode,et al.  The staphylocoagulase family of zymogen activator and adhesion proteins , 2004, Cellular and Molecular Life Sciences CMLS.

[39]  V. Wheaton,et al.  Domains specifying thrombin–receptor interaction , 1991, Nature.

[40]  E. Di Cera,et al.  Identification of residues linked to the slow-->fast transition of thrombin. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[41]  L. Mosyak,et al.  Crystal Structure of the GpIbα-Thrombin Complex Essential for Platelet Aggregation , 2003, Science.

[42]  R. Huber,et al.  The refined 1.9 A crystal structure of human alpha‐thrombin: interaction with D‐Phe‐Pro‐Arg chloromethylketone and significance of the Tyr‐Pro‐Pro‐Trp insertion segment. , 1989, The EMBO journal.

[43]  D. Turk,et al.  The refined 1.9‐Å X‐ray crystal structure of d‐Phe‐Pro‐Arg chloromethylketone‐inhibited human α‐thrombin: Structure analysis, overall structure, electrostatic properties, detailed active‐site geometry, and structure‐function relationships , 1992, Protein science : a publication of the Protein Society.

[44]  J. Huntington,et al.  Targeting thrombin--rational drug design from natural mechanisms. , 2003, Trends in pharmacological sciences.

[45]  F. Baglia,et al.  A Binding Site for Thrombin in the Apple 1 Domain of Factor XI (*) , 1996, The Journal of Biological Chemistry.

[46]  W. Bode,et al.  The transition of bovine trypsinogen to a trypsin-like state upon strong ligand binding. II. The binding of the pancreatic trypsin inhibitor and of isoleucine-valine and of sequentially related peptides to trypsinogen and to p-guanidinobenzoate-trypsinogen. , 1979, Journal of molecular biology.

[47]  A. Rezaie,et al.  Mutagenesis studies toward understanding the mechanism of the cofactor function of thrombomodulin. , 2005, Biophysical chemistry.

[48]  R. Huber,et al.  The thrombin E192Q–BPTI complex reveals gross structural rearrangements: implications for the interaction with antithrombin and thrombomodulin , 1997, The EMBO journal.

[49]  B. Grinnell,et al.  Mutation of Protease Domain Residues Lys37-39 in Human Protein C Inhibits Activation by the Thrombomodulin-Thrombin Complex without Affecting Activation by Free Thrombin* , 1996, The Journal of Biological Chemistry.

[50]  M. Aiach,et al.  Amino acids 225–235 of the protein C serine‐protease domain are important for the interaction with the thrombin‐thrombomodulin complex , 1995, FEBS letters.

[51]  C W Turck,et al.  Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes. , 1994, Biochemistry.

[52]  R. Huber,et al.  Three‐dimensional structure of porcine procarboxypeptidase B: a structural basis of its inactivity. , 1991, The EMBO journal.

[53]  Enrico Di Cera,et al.  Substrate Recognition Drives the Evolution of Serine Proteases* , 2002, The Journal of Biological Chemistry.

[54]  S. Coughlin,et al.  Protease‐activated receptors in hemostasis, thrombosis and vascular biology , 2005, Journal of thrombosis and haemostasis : JTH.

[55]  E. Di Cera,et al.  Thrombin is a Na(+)-activated enzyme. , 1992, Biochemistry.

[56]  J. Morser,et al.  TAFI, or Plasma Procarboxypeptidase B, Couples the Coagulation and Fibrinolytic Cascades through the Thrombin-Thrombomodulin Complex* , 1996, The Journal of Biological Chemistry.

[57]  S. W. Hall,et al.  An Extensive Interaction Interface between Thrombin and Factor V Is Required for Factor V Activation* , 2001, The Journal of Biological Chemistry.

[58]  H Brandstetter,et al.  Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics. , 1992, Journal of molecular biology.

[59]  C. Esmon,et al.  The molecular basis of thrombin allostery revealed by a 1.8 A structure of the "slow" form. , 2003, Structure.

[60]  R. Carrell,et al.  Crystal structures of native and thrombin-complexed heparin cofactor II reveal a multistep allosteric mechanism , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[61]  R. Huber,et al.  Refined structure of the hirudin-thrombin complex. , 1991, Journal of molecular biology.

[62]  L. Lorand,et al.  Promotion of thrombin-catalyzed activation of factor XIII by fibrinogen. , 1983, Biochemistry.

[63]  C. Gibbs,et al.  Crystal Structure of Anticoagulant Thrombin Variant E217K Provides Insights into Thrombin Allostery* , 2004, Journal of Biological Chemistry.

[64]  W. Bode,et al.  The refined crystal structure of bovine beta-trypsin at 1.8 A resolution. II. Crystallographic refinement, calcium binding site, benzamidine binding site and active site at pH 7.0. , 1975, Journal of molecular biology.

[65]  C. Sadasivan,et al.  Interaction of the factor XIII activation peptide with alpha -thrombin. Crystal structure of its enzyme-substrate analog complex. , 2000, The Journal of biological chemistry.

[66]  C. Noyes,et al.  Structural and functional properties of human alpha-thrombin, phosphopyridoxylated alpha-thrombin, and gamma T-thrombin. Identification of lysyl residues in alpha-thrombin that are critical for heparin and fibrin(ogen) interactions. , 1989, The Journal of biological chemistry.

[67]  W. Bode,et al.  Crystal structure of the thrombin‐hirudin complex: a novel mode of serine protease inhibition. , 1990, The EMBO journal.

[68]  C. Esmon,et al.  Involvement of Thrombin Anion-binding Exosites 1 and 2 in the Activation of Factor V and Factor VIII* , 1996, The Journal of Biological Chemistry.

[69]  W. Bode.  The structure of thrombin, a chameleon‐like proteinase , 2005, Journal of thrombosis and haemostasis : JTH.

[70]  E. Di Cera,et al.  The Na+ Binding Site of Thrombin (*) , 1995, The Journal of Biological Chemistry.

[71]  H. Halvorson,et al.  Quantitative characterization of the thrombin-heparin interaction. Discrimination between specific and nonspecific binding models. , 1991, The Journal of biological chemistry.

[72]  J. Sheehan,et al.  Molecular mapping of the heparin-binding exosite of thrombin. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[73]  S Foundling,et al.  The 2.8 A crystal structure of Gla‐domainless activated protein C. , 1996, The EMBO journal.

[74]  C. Esmon.  Thrombomodulin as a model of molecular mechanisms that modulate protease specificity and function at the vessel surface , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[75]  M. Nagashima,et al.  Amino Acid Residues in the P6-P′3 Region of Thrombin-activable Fibrinolysis Inhibitor (TAFI) Do Not Determine the Thrombomodulin Dependence of TAFI Activation* , 2002, The Journal of Biological Chemistry.

[76]  W. Bode,et al.  A player of many parts: the spotlight falls on thrombin's structure. , 1993, Thrombosis research.

[77]  S. Prasad,et al.  Molecular Dissection of Na+ Binding to Thrombin* , 2004, Journal of Biological Chemistry.

[78]  J. Parkinson,et al.  Alanine-scanning mutagenesis of the epidermal growth factor-like domains of human thrombomodulin identifies critical residues for its cofactor activity. , 1993, The Journal of biological chemistry.

[79]  Y. Konishi,et al.  Bovine thrombin complexed with an uncleavable analog of residues 7-19 of fibrinogen A alpha: geometry of the catalytic triad and interactions of the P1', P2', and P3' substrate residues. , 1996, Biochemistry.

[80]  E. Di Cera,et al.  Molecular recognition by thrombin. Role of the slow-->fast transition, site-specific ion binding energetics and thermodynamic mapping of structural components. , 1994, Journal of molecular biology.

[81]  L. Leung,et al.  Structural requirements for the activation of human factor VIII by thrombin. , 2002, Blood.

[82]  R. Huber,et al.  The structure of residues 7-16 of the A alpha-chain of human fibrinogen bound to bovine thrombin at 2.3-A resolution. , 1994, The Journal of biological chemistry.

[83]  P. Gettins.  Serpin structure, mechanism, and function. , 2002, Chemical reviews.

[84]  W. Bode,et al.  The clot thickens: clues provided by thrombin structure. , 1995, Trends in biochemical sciences.

[85]  M. Overduin,et al.  The plot thickens: How thrombin modulates blood clotting , 2000, Nature Structural Biology.

[86]  J. Huntington,et al.  Crystal Structure of Thrombin Bound to Heparin* , 2005, Journal of Biological Chemistry.

[87]  C. Esmon,et al.  Glu-192----Gln substitution in thrombin mimics the catalytic switch induced by thrombomodulin. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[88]  W. Bode,et al.  Fibrinogen Substrate Recognition by Staphylocoagulase·(Pro)thrombin Complexes* , 2006, Journal of Biological Chemistry.

[89]  R. Huber,et al.  The structure of a complex of recombinant hirudin and human alpha-thrombin. , 1990, Science.

[90]  P. Walsh,et al.  Roles of factor XI, platelets and tissue factor‐initiated blood coagulation , 2003, Journal of thrombosis and haemostasis : JTH.

[91]  J. Ware,et al.  Modulation of α-Thrombin Function by Distinct Interactions with Platelet Glycoprotein Ibα , 2003, Science.

[92]  E. Davie,et al.  A Brief Historical Review of the Waterfall/Cascade of Blood Coagulation , 2003, Journal of Biological Chemistry.

[93]  W. Bode,et al.  Structural Basis for Reduced Staphylocoagulase-mediated Bovine Prothrombin Activation* , 2006, Journal of Biological Chemistry.

[94]  V. De Filippis,et al.  Effect of Na+ binding on the conformation, stability and molecular recognition properties of thrombin. , 2005, The Biochemical journal.